Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?
The blood–brain barrier (BBB) is a barrier that separates the blood from the brain tissue and possesses unique characteristics that make the delivery of drugs to the brain a great challenge. To achieve this purpose, it is necessary to design strategies to allow BBB passage, in order to reach the bra...
Guardado en:
Autores principales: | Rúben G. R. Pinheiro, Ana Joyce Coutinho, Marina Pinheiro, Ana Rute Neves |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f8f503332d9e40ada4177774d6bea6d7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Liposome based drug delivery as a potential treatment option for Alzheimer’s disease
por: Carely Hernandez, et al.
Publicado: (2022) -
Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases
por: Claudia Riccardi, et al.
Publicado: (2021) -
Topical Insights Into the Post-Approval Controversies of Aducanumab
por: Dhiraj Kumar, et al.
Publicado: (2021) -
Gut Microbiota Regulation and Their Implication in the Development of Neurodegenerative Disease
por: Peilin Sun, et al.
Publicado: (2021) -
Drug delivery
Publicado: (1993)